---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-061120"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T21:21:16.574358+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Fulgent Genetics announces 2024 annual meeting voting results

## Summary
- All four director nominees elected: Ming Hsieh, Michael Nohaile, Regina Groves, Linda Marsh (votes for ranged ~15.8M to 20.0M).
- Ratification of Deloitte & Touche as auditor for FY2024 approved with 24.2M votes for.
- Advisory vote on executive compensation approved with 19.8M votes for.
- Approximately 82% of eligible shares (24.5M of 29.9M) present at meeting.

## SEC filing metadata
- accession: 0000950170-24-061120
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000095017024061120/0000950170-24-061120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000095017024061120/flgt-20240516.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-061120
- JSON: https://secwatch.observer/filing/0000950170-24-061120.json
- Plain text: https://secwatch.observer/filing/0000950170-24-061120.txt

## Source-grounded claims
- claim_id: 3ecb177bda0e6c216ac42e7366fc1a740a734850
  claim: Fulgent Genetics, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-16 meeting.
  evidence_excerpt: Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1674930/000095017024061120/0000950170-24-061120-index.htm
- claim_id: cbe397195d7c8c12c40e9bed9cd541486a77623c
  claim: Fulgent Genetics, Inc. shareholders approved Approval, on a non-binding advisory basis, the compensation of the Company's named executive officers at the 2024-05-16 meeting.
  evidence_excerpt: Proposal 3 Approval, on a non-binding advisory basis, the compensation of the Company’s named executive officers. Votes For Votes Against Votes Abstained Broker Non-Vote 19,786,239 573,411 25,950 4,095,268
  evidence_url: https://www.sec.gov/Archives/edgar/data/1674930/000095017024061120/0000950170-24-061120-index.htm
- claim_id: e747ff9b266d931532ddff2464826880a2a5caeb
  claim: Fulgent Genetics, Inc. shareholders approved Election of directors at the 2024-05-16 meeting.
  evidence_excerpt: Proposal 1 Election of the following nominees as directors of the Company, each to serve until the 2025 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified. Votes For Votes Withheld Broker Non-Vote Ming Hsieh 20,071,185 314,415 4,095,268 Michael Nohaile, Ph.D. 17,462,830 2,922,770 4,095,268 Regina Groves 17,487,701 2,897,899 4,095,268 Linda Marsh 15,854,682 4,530,918 4,095,268
  evidence_url: https://www.sec.gov/Archives/edgar/data/1674930/000095017024061120/0000950170-24-061120-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.